Not Yet Recruiting
CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia
NCT07008872
- Conditions
- CD7+ Acute Leukemia, CD7+ Lymphoma, Hemic and Lymphatic Diseases, +7 more
- Locations
-
Not specified